Volume 26, Issue 2, Pages e4 (February 2018)

Slides:



Advertisements
Similar presentations
Structural Basis for Substrate Selectivity of the E3 Ligase COP1
Advertisements

Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Volume 25, Issue 4, Pages e3 (April 2017)
Volume 16, Issue 6, Pages (June 2008)
Structure of an LDLR-RAP Complex Reveals a General Mode for Ligand Recognition by Lipoprotein Receptors  Carl Fisher, Natalia Beglova, Stephen C. Blacklow 
Volume 25, Issue 4, Pages e3 (April 2017)
Hierarchical Binding of Cofactors to the AAA ATPase p97
The Structure of the Cytoplasmic Domain of the Chloride Channel ClC-Ka Reveals a Conserved Interaction Interface  Sandra Markovic, Raimund Dutzler  Structure 
Protein Kinase C Regulation: C1 Meets C-tail
Structure and Intrinsic Disorder in Protein Autoinhibition
Volume 21, Issue 9, Pages (September 2013)
Xiaojing He, Yi-Chun Kuo, Tyler J. Rosche, Xuewu Zhang  Structure 
Volume 64, Issue 3, Pages (November 2016)
Volume 28, Issue 3, Pages (November 2007)
Volume 16, Issue 10, Pages (October 2008)
Xuewu Zhang, Jodi Gureasko, Kui Shen, Philip A. Cole, John Kuriyan 
Volume 18, Issue 9, Pages (September 2010)
Volume 36, Issue 4, Pages (November 2009)
Volume 14, Issue 5, Pages (May 2006)
A Model for the Solution Structure of the Rod Arrestin Tetramer
Volume 137, Issue 7, Pages (June 2009)
Charlotte Hodson, Andrew Purkiss, Jennifer Anne Miles, Helen Walden 
Volume 19, Issue 2, Pages (February 2011)
Volume 25, Issue 5, Pages e3 (May 2017)
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Structural and Functional Studies of the 252 kDa Nucleoporin ELYS Reveal Distinct Roles for Its Three Tethered Domains  Silvija Bilokapic, Thomas U. Schwartz 
Volume 16, Issue 6, Pages (June 2008)
Volume 106, Issue 6, Pages (September 2001)
Volume 21, Issue 8, Pages (August 2013)
Structural Basis for the Differential Effects of CaBP1 and Calmodulin on CaV1.2 Calcium-Dependent Inactivation  Felix Findeisen, Daniel L. Minor  Structure 
Structural Analysis of Ligand Stimulation of the Histidine Kinase NarX
Structure and Site-Specific Recognition of Histone H3 by the PHD Finger of Human Autoimmune Regulator  Suvobrata Chakravarty, Lei Zeng, Ming-Ming Zhou 
Volume 19, Issue 12, Pages (December 2011)
Raf-1 Cysteine-Rich Domain Increases the Affinity of K-Ras/Raf at the Membrane, Promoting MAPK Signaling  Shuai Li, Hyunbum Jang, Jian Zhang, Ruth Nussinov 
Structural Basis of EZH2 Recognition by EED
Volume 42, Issue 1, Pages 9-22 (April 2011)
Crystal Structure of the p53 Core Domain Bound to a Full Consensus Site as a Self- Assembled Tetramer  Yongheng Chen, Raja Dey, Lin Chen  Structure  Volume.
David Jeruzalmi, Mike O'Donnell, John Kuriyan  Cell 
The Unmasking of Telomerase
Volume 23, Issue 9, Pages (September 2015)
Volume 15, Issue 2, Pages (February 2007)
Volume 26, Issue 1, Pages e7 (January 2018)
Meigang Gu, Kanagalaghatta R. Rajashankar, Christopher D. Lima 
Volume 23, Issue 6, Pages (June 2015)
Volume 23, Issue 9, Pages (September 2015)
Structural Basis for Substrate Selectivity of the E3 Ligase COP1
Volume 29, Issue 6, Pages (March 2008)
Shiqian Qi, Do Jin Kim, Goran Stjepanovic, James H. Hurley  Structure 
David Jeruzalmi, Mike O'Donnell, John Kuriyan  Cell 
The Active Conformation of the PAK1 Kinase Domain
Jeffrey J. Wilson, Rhett A. Kovall  Cell 
Volume 12, Issue 1, Pages (July 2015)
Volume 24, Issue 9, Pages (September 2016)
Structural Insight into BLM Recognition by TopBP1
A YidC-like Protein in the Archaeal Plasma Membrane
GTP-Dependent K-Ras Dimerization
Jue Wang, Jia-Wei Wu, Zhi-Xin Wang  Structure 
Volume 26, Issue 4, Pages e4 (April 2018)
Volume 21, Issue 1, Pages (January 2013)
Volume 19, Issue 8, Pages (August 2011)
Eva M. Huber, Michael Groll  Structure 
Volume 26, Issue 5, Pages e3 (May 2018)
Volume 14, Issue 3, Pages (March 2006)
Volume 23, Issue 9, Pages (September 2015)
A Model for the Solution Structure of the Rod Arrestin Tetramer
Matthieu Chavent, Elena Seiradake, E. Yvonne Jones, Mark S.P. Sansom 
Volume 25, Issue 11, Pages e3 (November 2017)
Brett K. Kaiser, Matthew C. Clifton, Betty W. Shen, Barry L. Stoddard 
Volume 21, Issue 6, Pages (June 2013)
Volume 25, Issue 1, Pages (January 2017)
Presentation transcript:

Volume 26, Issue 2, Pages 270-281.e4 (February 2018) Regulation of Kinase Activity in the Caenorhabditis elegans EGF Receptor, LET-23  Lijun Liu, Tarjani M. Thaker, Daniel M. Freed, Nicole Frazier, Ketan Malhotra, Mark A. Lemmon, Natalia Jura  Structure  Volume 26, Issue 2, Pages 270-281.e4 (February 2018) DOI: 10.1016/j.str.2017.12.012 Copyright © 2017 Elsevier Ltd Terms and Conditions

Structure 2018 26, 270-281.e4DOI: (10.1016/j.str.2017.12.012) Copyright © 2017 Elsevier Ltd Terms and Conditions

Figure 1 Phylogenetic Tree of EGFR Kinase Domain Protein Sequences in the Animal Kingdom The tree was assembled from 71 sequences representing EGFR kinase domains in 30 different species aligned using MUSCLE 3.7 (Edgar, 2004). The tree was built using the phylogeny software PhyML 3.0 based on the maximum likelihood principle (Anisimova and Gascuel, 2006; Dereeper et al., 2008). Degrees of protein sequence conservation in the regions corresponding to the allosteric activator interface (Activator), receiver interface (Receiver), and the juxtamembrane latch (JM latch) are indicated by different colors. EGF receptors predicted to be inactive are marked by boxes. See also Tables S1 and S2. Structure 2018 26, 270-281.e4DOI: (10.1016/j.str.2017.12.012) Copyright © 2017 Elsevier Ltd Terms and Conditions

Figure 2 Crystal Structure of the LET-23 Kinase Domain (A) The structure of the inactive C. elegans LET-23 kinase domain in complex with AMP-PNP compared with the structures of the inactive human EGFR V924R kinase in complex with AMP-PNP (PDB: 5CNO) and active human EGFR kinase in complex with an ATP analog (PDB: 2GS6). (B) Detailed view of structural elements in the N-lobe of the LET-23 kinase domain overlaid on the structure of the inactive human EGFR V924R kinase domain (PDB: 5CNO) highlighting features of the C helix interaction with the activation loop. (C) Comparison of C-tail binding modes in inactive human EGFR V924R kinase domains (PDB: 5CNO) (left), active human EGFR kinase domain (PDB: 2GS6), and inactive LET-23 kinase domain. (D) Detailed view of interactions between the C-tail and the hinge region in the crystal structures of LET-23 and inactive human EGFR V924R kinase domains (PDB: 5CNO). (E) The left panel shows two LET-23 kinases interacting via the C-terminal tail/C-lobe interface observed in the crystal lattice. The two right panels highlight interactions in the C-lobe interface in LET-23 (middle panel) and EGFR (right panel) with the C tail in LET-23 or Mig6 in EGFR (PDB: 2RFE). See also Figure S1. Structure 2018 26, 270-281.e4DOI: (10.1016/j.str.2017.12.012) Copyright © 2017 Elsevier Ltd Terms and Conditions

Figure 3 Catalytic Activity of the LET-23 Kinase Domain in Solution and Associated with Lipid Vesicles (A) Specific activity of the LET-23 and human EGFR kinase domain, each at 1 μM, in solution (light gray) and linked to vesicles (dark gray) containing 5 mol % DOGS-NTA-Ni. (B) Concentration-dependent activation of the LET-23 kinase domain upon association with lipid vesicles. The specific activities of the kinase domain in solution or on vesicles containing increasing mole percentages of DOGS-NTA-Ni are shown. In all measurements, the ratio of protein to total lipids in bulk solution was fixed at 1 μM and 12.5 μM, respectively. Data are represented as mean ± SD. (C) Alignment of the activation loop sequences of LET-23 and the human EGFR kinase domain. Structure 2018 26, 270-281.e4DOI: (10.1016/j.str.2017.12.012) Copyright © 2017 Elsevier Ltd Terms and Conditions

Figure 4 Structural Analysis of the LET-23 Asymmetric Dimer Model (A) Upper panel: sequence alignment of LET-23 and human EGFR kinase domain within the region containing residues involved in the activator interface. Residues in the activator interface are denoted by rectangles, which are blue if the residues are depicted on cartoon images in lower panels. Lower panels: detailed view of the asymmetric dimer interface in the human EGFR kinase dimer (PDB: 2GS6) (left panels), and in the homology model of the LET-23 asymmetric dimer (right panels). The key interfacial residues on the activator interface are shown in stick and dot representation. Residue E1153 in the LET-23 C-lobe was included in the original structure, but removed during generation of the homology model, likely due to unfavorable interactions with the LET-23 N-lobe in the asymmetric dimer model. (B) Upper panel: sequence alignment of LET-23 and human EGFR kinase domain within the region containing residues involved in the receiver interface. Residues in the activator interface are denoted by ovals, which are dark orange if the residues are depicted on cartoon images in lower panels. Lower panels: detailed view of the receiver interface of the active human EGFR kinase dimer (PDB: 2GS6) (left panels), and in the homology model of the LET-23 asymmetric dimer (right panels). The key interfacial residues on the activator interface are shown in stick and dot representation. The electrostatic surface potentials shown for the activator and receiver interfaces were calculated using APBS (Baker et al., 2001). Structure 2018 26, 270-281.e4DOI: (10.1016/j.str.2017.12.012) Copyright © 2017 Elsevier Ltd Terms and Conditions

Figure 5 Role of the Asymmetric Dimer Interface in Activation of the LET-23 Kinase Domain (A) Specific activity of the wild-type and mutant LET-23 kinase constructs at 1 μM, linked to vesicles containing 5 mol % DOGS-NTA-Ni. (B) Specific activity measurements for the wild-type (WT), L877Q, and L1121R constructs alone collected at 2 μM protein concentrations. In the L877Q/L1121R condition, each protein was present in the reaction mixture at 1 μM (2 μM total concentration). Data were collected on vesicles containing 5 mol % DOGS-NTA-Ni. (C) Western blot analysis of LIN-3EGF-induced phosphorylation of full-length wild type of mutant LET-23 constructs upon transient transfection in COS-7 cells and immunoprecipitation with the anti-FLAG antibody. LIN-3EGF corresponds to the purified EGF domain from LIN-3, as previously described (Freed et al., 2015). (D) Specific activity of the wild-type and mutant LET-23 kinase constructs linked to vesicles containing 5 mol % DOGS-NTA-Ni. (E) Hypothesized EGFR-like asymmetric dimer pairings between the wild-type and mutant LET-23 kinases mixed at equimolar concentrations. Green check marks indicate activity, black crosses indicate no activity. Specific activity data are represented as mean ± SD. Structure 2018 26, 270-281.e4DOI: (10.1016/j.str.2017.12.012) Copyright © 2017 Elsevier Ltd Terms and Conditions